Baxter advances turnaround with GPS system
Teams launched over 230 continuous improvement events in Q1 2026, stabilizing business and strengthening balance sheet.
See the latest news and media coverage for Baxter. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of medical devices, clinical nutrition, and connected-care solutions
baxter.comLast updated
In short: Baxter agreed to sell its kidney care and biopharma units for over $8 billion while launching new smart medical devices to stabilize its business.
Teams launched over 230 continuous improvement events in Q1 2026, stabilizing business and strengthening balance sheet.
Sales from continuing operations reached $2.7 billion, up 3% reported but down 1% organic. Adjusted EPS was $0.36. Full-year outlook reiterated.
Baxter earns Highest Member Choice Award for Supplier Resiliency, Distinguished Member Choice Award for Supplier Transparency, and 2026 Transparency Badge for fourth year. Alan Mavis discusses resiliency.
The automated solution streamlines nursing workflows, saves time, and reduces medication errors with standardized labels. It results from a partnership with Vigilant Software.
On June 17, 2026, Baxter International Inc (BAX) shares fell 5.2% today, bringing the current price to $19.39. The stock has experienced significant volatility...
Long-established in the Medical Devices & Instruments industry, Baxter International Inc BAX has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth...
With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included...
Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts...
Track Baxter and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Baxter and other trending companies.